LUPINI, Laura
 Distribuzione geografica
Continente #
NA - Nord America 4.681
AS - Asia 2.321
EU - Europa 1.750
SA - Sud America 301
AF - Africa 51
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 2
Totale 9.109
Nazione #
US - Stati Uniti d'America 4.562
SG - Singapore 871
CN - Cina 564
IT - Italia 388
DE - Germania 294
VN - Vietnam 280
PL - Polonia 273
BR - Brasile 225
FI - Finlandia 189
HK - Hong Kong 171
GB - Regno Unito 155
TR - Turchia 132
UA - Ucraina 103
SE - Svezia 67
CA - Canada 62
FR - Francia 62
IN - India 53
BD - Bangladesh 50
JP - Giappone 49
ID - Indonesia 43
MX - Messico 43
RU - Federazione Russa 43
BE - Belgio 31
NL - Olanda 30
AR - Argentina 27
RO - Romania 21
CZ - Repubblica Ceca 19
ZA - Sudafrica 19
IQ - Iraq 18
AT - Austria 16
ES - Italia 15
LT - Lituania 12
PK - Pakistan 12
CO - Colombia 11
CL - Cile 9
IE - Irlanda 9
TN - Tunisia 9
EC - Ecuador 8
EG - Egitto 8
IR - Iran 7
PH - Filippine 7
SA - Arabia Saudita 7
UZ - Uzbekistan 7
VE - Venezuela 7
MY - Malesia 6
PE - Perù 6
AE - Emirati Arabi Uniti 5
BO - Bolivia 5
DZ - Algeria 5
KZ - Kazakistan 5
OM - Oman 5
AL - Albania 4
JO - Giordania 4
NP - Nepal 4
AU - Australia 3
GR - Grecia 3
KE - Kenya 3
LV - Lettonia 3
MA - Marocco 3
TW - Taiwan 3
BH - Bahrain 2
CH - Svizzera 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
IL - Israele 2
JM - Giamaica 2
LA - Repubblica Popolare Democratica del Laos 2
LK - Sri Lanka 2
NO - Norvegia 2
PA - Panama 2
PY - Paraguay 2
QA - Qatar 2
TT - Trinidad e Tobago 2
BB - Barbados 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CY - Cipro 1
DK - Danimarca 1
EE - Estonia 1
EU - Europa 1
GD - Grenada 1
HN - Honduras 1
HR - Croazia 1
LB - Libano 1
LU - Lussemburgo 1
MN - Mongolia 1
MQ - Martinica 1
MT - Malta 1
PS - Palestinian Territory 1
RS - Serbia 1
SI - Slovenia 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TL - Timor Orientale 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 9.109
Città #
Ashburn 595
Singapore 519
Fairfield 430
Woodbridge 349
San Jose 330
Warsaw 271
Houston 228
Ann Arbor 223
Beijing 211
Chandler 203
Santa Clara 177
Seattle 177
Munich 171
Hong Kong 170
Cambridge 135
Wilmington 128
Jacksonville 126
New York 116
Ferrara 114
Helsinki 113
Dallas 108
Ho Chi Minh City 94
Los Angeles 75
Izmir 66
Milan 55
Hanoi 53
Tokyo 49
Turku 47
Shanghai 46
Nanjing 45
Princeton 37
Council Bluffs 36
Jakarta 36
Orem 36
Lauterbourg 34
Brussels 31
London 28
Mexico City 27
San Diego 27
Buffalo 25
Boardman 23
Tianjin 23
Chicago 22
São Paulo 22
Nanchang 21
Rome 21
Atlanta 19
Bremen 19
Phoenix 19
Montreal 18
Addison 17
Da Nang 17
Denver 17
Timisoara 17
Toronto 17
Falls Church 16
Bologna 15
Brooklyn 15
Amsterdam 14
Chennai 14
Johannesburg 14
Brno 13
Dong Ket 13
Shenyang 13
The Dalles 13
Changsha 12
Haiphong 12
Nuremberg 12
Manchester 11
Stockholm 11
Boston 10
Poplar 10
Redwood City 10
Rio de Janeiro 10
Dearborn 9
Dublin 9
Hebei 9
Moscow 9
San Francisco 9
Washington 9
Barnet 8
Columbus 8
Frankfurt am Main 8
Kunming 8
Charlotte 7
Naples 7
Santiago 7
Ankara 6
Auburn Hills 6
Baghdad 6
Belo Horizonte 6
Falkenstein 6
Hangzhou 6
Hefei 6
Jiaxing 6
Mountain View 6
Philadelphia 6
Salt Lake City 6
Tampa 6
Vienna 6
Totale 6.456
Nome #
Absolute quantification of cell-free microRNAs in cancer patients 333
In CLL, comorbidities and the complex karyotype are associated with an inferior outcome independently of CLL-IPI 315
A microRNA signature to predict risk progression of vulvar lichen sclerosus to squamous cell carcinoma 303
Circulating miR-106b-3p, miR-101-3p and miR-1246 as diagnostic biomarkers of hepatocellular carcinoma 301
High-sensitivity assay for monitoring ESR1 mutations in circulating cell-free DNA of breast cancer patients receiving endocrine therapy 297
Liver tumorigenicity promoted by microRNA-221 in a mouse transgenic model 286
Chromosome aberrations detected by conventional karyotyping using novel mitogens in chronic lymphocytic leukemia: Clinical and biologic correlations. 274
Extensive next-generation sequencing analysis in chronic lymphocytic leukemia at diagnosis: Clinical and biological correlations 272
Ruolo del miR-221 nella tumorigenesi epatica 271
An extensive molecular cytogenetic characterization in high-risk chronic lymphocytic leukemia identifies karyotype aberrations and TP53 disruption as predictors of outcome and chemorefractoriness 270
An extensive molecular cytogenetic characterization in high-risk chronic lymphocytic leukemia identifies karyotype aberrations and TP53 disruption as predictors of outcome and chemorefractoriness 263
In chronic lymphocytic leukaemia with complex karyotype, major structural abnormalities identify a subset of patients with inferior outcome and distinct biological characteristics 249
Downregulation of the mitochondrial calcium uniporter by cancer-related miR-25 246
miR-125b targets erythropoietin and its receptor and their expression correlates with metastatic potential and ERBB2/HER2 expression 243
Genetic subclonal complexity and miR125a-5p down-regulation identify a subset of patients with inferior outcome in low-risk CLL patients 241
Circulating non-coding RNA as biomarkers in colorectal cancer 238
HER2-Positive Lobular Versus Ductal Carcinoma of the Breast: Pattern of First Recurrence and Molecular Insights 233
Chromosome aberrations detected by conventional karyotyping using novel mitogens in chronic lymphocytic leukemia: Clinical and biologic correlations 230
Circulating microRNA quantification using DNA-binding dye chemistry and droplet digital PCR 224
Quantification of circulating miRNAs by droplet digital PCR: Comparison of EvaGreen- and TaqMan-based chemistries 222
Erratum to: Extensive next-generation sequencing analysis in chronic lymphocytic leukemia at diagnosis: clinical and biological correlations (J Hematol Oncol. (2016) 9 (88) DOI:10.1186/s13045-016-0320-z) 220
Over-expression of the miR-483-3p overcomes the miR-145/TP53 pro-apoptotic loop in hepatocellular carcinoma 215
Circulating tumor DNAs and non-coding RNAs as potential biomarkers for hepatocellular carcinoma diagnosis, prognosis and response to therapy 209
Estrogen receptor mutation: a new strategy to overcome endocrine resistance 207
MicroRNAs involvement in fludarabine refractory chronic lymphocytic leukemia 206
BCR/ABL1-positive acute lymphoblastic leukemia relapsing as BCR/ABL1-negative acute lymphoblastic leukemia 206
Molecular biomarkers predicting early development of endometrial carcinoma: A pilot study 187
Mutated beta-catenin evades a microRNA-dependent regulatory loop 187
MiR-145 participates with TP53 in a death promoting regulatory loop and targets estrogen receptor in human breast cancer cells 184
Molecular testing on bronchial washings for the diagnosis and predictive assessment of lung cancer 180
Inhibiting the oncogenic mir-221 by microRNA sponge: Toward microRNA-based therapeutics for hepatocellular carcinoma 173
Oncogenic role of miR-483-3p at the IGF2/483 locus 170
Genetic dynamics in untreated CLL patients with either stable or progressive disease: A longitudinal study 170
Monitoring Somatic Genetic Alterations in Circulating Cell-Free DNA/RNA of Patients with "Oncogene-Addicted" Advanced Lung Adenocarcinoma: A Real-World Clinical Study 169
Prediction of response to anti-EGFR antibody-based therapies by multigene sequencing in colorectal cancer patients 167
MicroRNA Expression Profiling and Its Clinical Impact in Breast Cancer 163
The importance of microRNAs in RAS oncogenic activation in human cancer 152
Microbiota and environmental health monitoring of mouse colonies by metagenomic shotgun sequencing 134
miR-221 affects multiple cancer pathways by modulating the level of hundreds messenger RNAs 128
Circulating miR-1246 and miR-485-3p as Promising Biomarkers of Clinical Response and Outcome in Melanoma Patients Treated with Targeted Therapy 126
How to fish a good micro-marker out from a worthless lake: The case of cell-free miR-181a-5p and breast cancer 119
null 89
null 77
null 63
Totale 9.212
Categoria #
all - tutte 38.690
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.676
Totale 40.366


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202168 0 0 0 0 0 0 0 0 0 0 0 68
2021/2022451 23 30 30 23 23 23 45 24 16 33 53 128
2022/2023474 48 41 29 67 66 72 35 31 52 2 17 14
2023/2024332 28 36 11 5 31 85 16 28 7 8 5 72
2024/20251.520 35 35 95 78 147 171 93 69 309 114 183 191
2025/20263.527 389 135 267 394 502 242 488 220 386 323 168 13
Totale 9.212